These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 16265185)

  • 21. American Gastroenterological Association medical position statement: guidelines on osteoporosis in gastrointestinal diseases.
    Gastroenterology; 2003 Mar; 124(3):791-4. PubMed ID: 12612916
    [No Abstract]   [Full Text] [Related]  

  • 22. [Daily practice using the guidelines for prevention and treatment of osteoporosis. Utilization of metabolic markers of bone in daily osteoporosis practice].
    Miki T; Masaki H
    Clin Calcium; 2008 Aug; 18(8):1127-34. PubMed ID: 18677050
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Osteoporosis in inflammatory bowel disease.
    Ali T; Lam D; Bronze MS; Humphrey MB
    Am J Med; 2009 Jul; 122(7):599-604. PubMed ID: 19559158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Osteopenia and osteoporosis in inflammatory bowel disease].
    Garcia-Planella E; Domènech E
    Gastroenterol Hepatol; 2004; 27(7):417-24. PubMed ID: 15461942
    [No Abstract]   [Full Text] [Related]  

  • 25. Bone disease in the inflammatory bowel disease population.
    Smith J; Lidofsky S
    Med Health R I; 2009 Apr; 92(4):125-7. PubMed ID: 19452755
    [No Abstract]   [Full Text] [Related]  

  • 26. Assessment of fracture risk: who should be treated for osteoporosis?
    van der Klift M; de Laet CD; Pols HA
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):937-50. PubMed ID: 16301188
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gut, inflammation and osteoporosis: basic and clinical concepts.
    Tilg H; Moschen AR; Kaser A; Pines A; Dotan I
    Gut; 2008 May; 57(5):684-94. PubMed ID: 18408105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High prevalence of morphometric vertebral deformities in patients with inflammatory bowel disease.
    Heijckmann AC; Huijberts MS; Schoon EJ; Geusens P; de Vries J; Menheere PP; van der Veer E; Wolffenbuttel BH; Stockbrugger RW; Dumitrescu B; Nieuwenhuijzen Kruseman AC
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):740-7. PubMed ID: 18617778
    [TBL] [Abstract][Full Text] [Related]  

  • 29. All patients with inflammatory bowel disease should have bone density assessment: pro.
    Papaioannou A; Ferko NC; Adachi JD
    Inflamm Bowel Dis; 2001 May; 7(2):158-62; discussion 168-9. PubMed ID: 11383589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Detection of osteoporosis in patients with inflammatory bowel disease.
    Compston JE
    Eur J Gastroenterol Hepatol; 1997 Oct; 9(10):931-3. PubMed ID: 9391779
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guidelines do help change behavior in the management of osteoporosis by gastroenterologists.
    Kane S; Reddy D
    Am J Gastroenterol; 2006 Aug; 101(8):1841-4. PubMed ID: 16817840
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of risedronate in osteoporotic postmenopausal women with inflammatory bowel disease: a prospective, parallel, open-label, two-year extension study.
    Palomba S; Manguso F; Orio F; Russo T; Oppedisano R; Sacchinelli A; Falbo A; Tolino A; Zullo F; Mastrantonio P
    Menopause; 2008; 15(4 Pt 1):730-6. PubMed ID: 18698280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Glucocorticoid-induced osteoporosis treatment algorithm].
    Payer J; Killinger Z; Brázdilová K
    Vnitr Lek; 2009 May; 55(5):506-11. PubMed ID: 19514617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low body mass not vitamin D receptor polymorphisms predict osteoporosis in patients with inflammatory bowel disease.
    Noble CL; McCullough J; Ho W; Lees CW; Nimmo E; Drummond H; Bear S; Hannan J; Millar C; Ralston SH; Satsangi J
    Aliment Pharmacol Ther; 2008 Apr; 27(7):588-96. PubMed ID: 18194505
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Osteoporosis: whom, when and how to treat?].
    Stepán J
    Cas Lek Cesk; 2009; 148(1):25-33. PubMed ID: 19634279
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Keeping a broad approach to managing pediatric bone disease.
    Polgreen LE
    J Pediatr Gastroenterol Nutr; 2010 Aug; 51(2):128-9. PubMed ID: 20512055
    [No Abstract]   [Full Text] [Related]  

  • 37. The prevention and treatment of osteoporosis: a review.
    Cosman F
    MedGenMed; 2005 May; 7(2):73. PubMed ID: 16369451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of calcium and vitamin D supplementation on bone mineral density in children with inflammatory bowel disease.
    Benchimol EI; Ward LM; Gallagher JC; Rauch F; Barrowman N; Warren J; Beedle S; Mack DR
    J Pediatr Gastroenterol Nutr; 2007 Nov; 45(5):538-45. PubMed ID: 18030230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Osteoporosis disease management for fragility fracture patients: new understandings based on three years' experience with an osteoporosis care service.
    Harrington JT; Lease J
    Arthritis Rheum; 2007 Dec; 57(8):1502-6. PubMed ID: 18050169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Glucocorticoid-induced osteoporosis: a review on pathophysiology and treatment options.
    De Nijs RN
    Minerva Med; 2008 Feb; 99(1):23-43. PubMed ID: 18299694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.